AUTHORITY FOR USING OTHER. FULL AND OPEN COMPETITION: NA 14.ACCOUNTING AND APPROPRIATION DATA E1N#061506689-A1 SOC 25.55 FY2004 $3,545,113 CAN# 4-8460923 ¨ 10 U.S.C. 2304(c)( ) ¨ 41 U.S.C. 253(c)( ) 15A. ITEMNO. 15B. SUPPLIES/SERVICES 15C. UNIT PRICE 15D. AMOUNT 15E. UNIT PRICE 15F. AMOUNT Title: Innate Immune Receptors and Adjuvant Discovery Period: June 30, 2004 through June 29,2009 Amount Allotted: $3,545,113 Contract Type: Cost-Reimbursement/Completion FY 04 $3,545,113 FY 05 $2,970,509 FY 06 $3,704,797 FY 07 $3,295,677 FY 08 $3,386,018 15G. TOTAL AMOUNT OF CONTRACT Ø $16,902,114 16. TABLE OF CONTENTS PART I - THE SCHEDULE PART II - CONTRACT CLAUSES x A SOLICITATION/CONTRACT FORM 1 x I CONTRACT CLAUSES 17 x B SUPPLIES OR SERVICES AND PRICE/COST 2 PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACH. x C DESCRIPTION/SPECS./WORK STATEMENT 5 x J LIST OF ATTACHMENTS 22 x E INSPECTION AND ACCEPTANCE 8 x K REPRESENTATIONS, CERTIFICATIONS AND OTHER STATEMENTS OF OFFERORS 23 x F DELIVERIES OR PERFORMANCE 8 x G CONTRACT ADMINISTRATION DATA 9 ¨ L INSTRS., CONDS., AND NOTICES TO OFFERORS x H SPECIAL CONTRACT REQUIREMENTS 12 ¨ M EVALUATION FACTORS FOR AWARD CONTRACTING OFFICER WILL COMPLETE ITEM 17 OR 18 AS APPLICABLE 17. x CONTRACTOR’S NEGOTIATED AGREEMENT (Contractor is required to sign this document and return 2 copies to issuing office:) Contractor agrees to furnish and deliver all items or perform all the services set forth or otherwise identified above and on any continuation sheets for the consideration stated herein. The rights and obligations of the parties to this contract shall be subject to and governed by the following documents: (a) this award/contract, (b) the solicitation, if any, and (c) such provisions, representations, certifications, and specifications, as are attached or incorporated by reference herein. (Attachments are listed herein.) 18. ¨ AWARD (Contractor is not required to sign this document.) Your offer on Solicitation Number , including the additions or changes made by you which additions or changes are set forth in full above, is hereby accepted as to the items listed above and on any continuation sheets. This award consummates the contract which consists of the following documents: (a) the Government’s solicitation and your offer, and (b) this award/contract. No further contractual document is necessary.
AUTHORITY FOR USING OTHER. THAN FULL AND OPEN COMPETITION UNDER THE UNITED STATES CODE AT:
AUTHORITY FOR USING OTHER. Than Full And Open Competition: 14. Accounting And Appropriation Data x 10 U.S.C. 2304(c)( 1 ) x 41 U.S.C. 253(c)(1 ) 15A. Item No. 15B. Schedule Of Supplies/Services 15C. Quantity 15D. Unit 15E. Unit Price 15F. Amount SEE SCHEDULE CONTRACT TYPE: Firm-Fixed-Price Cost-Plus-Fixed-Fee KIND OF CONTRACT: Service Contracts Supply Contracts and Priced Orders Contract Expiration Date: 2011DEC31 15G. Total Amount Of Contract – $0.00
AUTHORITY FOR USING OTHER. THAN FULL AND OPEN COMPLETION
AUTHORITY FOR USING OTHER. THAN FULL AND OPEN COMPETITION: [ ] 10 U.S.C. 2304(c)( ) [ ] 41 U.S.C. 253(c)( ) 14. ACCOUNTING AND APPROPRIATION DATA See Schedule 15A. ITEM NO. 15B. SUPPLIES/ SERVICES SEE SCHEDULE 15C. QUANTITY 15D. UNIT 15E. UNIT PRICE 15F. AMOUNT 15G. TOTAL AMOUNT OF CONTRACT $5,598,600.00 EST
AUTHORITY FOR USING OTHER. THAN FULL AND OPEN COMPETITION: 14. ACCOUNTING AND APPROPRIATION DATA o 10 U.S.C. 2304(c) ( ) o 41 U.S.C. 253(c) ( ) 15A. ITEM NO. 15B. SUPPLIES/SERVICES 15C. QUANTITY 15D. UNIT 15E. UNIT PRICE 15F. AMOUNT Title: Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine Period, September 30, 2003 through October 12, 2006 Amount Allotted: $29,410,000 Contact Type: Cost Plus Fixed Fee/Completion FY 03 FY 04 $29,410,000 $41,882,000 15Q TOTAL AMOUNT OF CONTRACT $71,292,000
AUTHORITY FOR USING OTHER. FULL AND OPEN COMPETITION: 14. ACCOUNTING AND APPROPRIATION DATA EIN 1-943236309-AI CAN 1991535 7550140 25.2A o 10 U.S.C. 2304(c)( ) o 41 U.S.C. 253(c)( ) 15A. ITEM NO. 15B. SUPPLIES/SERVICES 15C. 15D. UNIT 15E. UNIT PRICE 15F. PRICE Title: Acquisition of rPA Anthrax Vaccine for the Strategic National Stockpile Period: November 4, 2004 – November 3, 2009 Contract Type: IDIQ (Fixed Price Delivery Order and Cost Reimbursement Task Orders) FY 2005 $877,500,000 for 75 Million doses of rPA Anthrax Vaccine 15G. TOTAL AMOUNT OF CONTRACT „ $877,500,000
AUTHORITY FOR USING OTHER. THAN FULL AND OPEN COMPETITION: [ ] 10 U.S.C. 2304(c)( ) [ ] 41 U.S.C. 253(c)( )
AUTHORITY FOR USING OTHER. FULL AND OPEN COMPETITION: N/A 14. ACCOUNTING AND APPROPRIATION DATA ADB # N01-AI-40071 o 10 U.S.C. 2304(c)( ) o 41 U.S.C. 253(c)( ) EIN# ***** SOC# **** 04: $ ***** CAN# 4-8460924 15A. ITEM NO. 15B. SUPPLIES/SERVICES 15C. UNIT PRICE 15D. AMOUNT 15E. UNIT PRICE 15F. AMOUNT Title: FY 04 $***** Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine FY 05 ***** Period: September 30, 2004 through September 29, 2007 Amount Allotted: ***** Contract Type: Cost reimbursement/Completion 15G. TOTAL AMOUNT OF CONTRACT 4 $*****
AUTHORITY FOR USING OTHER. THAN FULL AND OPEN COMPETITION: 14 ACCOUNTING AND APPROPRIATION DATA 10U.S.C. 2304(c)( ) 41U.S.C. 253(c)( L N/A " 3 15A ITEM NO 1S8 SUPPLIESISERVICES . 15C. QUANTITY 150. UNIT -1 E. UNIT PRICE 15F. AMOUNT The Contractor agrees to the attached Blanket Purchase Agreement terms and conditions for provision of the services described in the attached statement of work. All work will ] be placed by orders. ,
